Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
67,113,783
-
Shares change
-
-27,851,334
-
Total reported value, excl. options
-
$28,852,000
-
Value change
-
-$14,814,454
-
Put/Call ratio
-
600%
-
Number of buys
-
17
-
Number of sells
-
-63
-
Price
-
$0.4299
Significant Holders of OREXIGEN THERAPEUTICS INC - COM (OREX) as of Q2 2016
104 filings reported holding OREX - OREXIGEN THERAPEUTICS INC - COM as of Q2 2016.
OREXIGEN THERAPEUTICS INC - COM (OREX) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67,113,783 shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (22,268,399 shares), SAMLYN CAPITAL, LLC (6,160,417 shares), Foresite Capital Management II, LLC (5,427,559 shares), BVF INC/IL (5,252,100 shares), VANGUARD GROUP INC (4,310,537 shares), MORGAN STANLEY (3,363,185 shares), Foresite Capital Management III, LLC (2,542,575 shares), BlackRock Institutional Trust Company, N.A. (2,136,522 shares), BlackRock Fund Advisors (1,956,345 shares), and Palo Alto Investors, LLC (1,673,024 shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.